 |
|
Study finds a high caloric diet may prevent the progression of amyotrophic lateral sclerosis
April 18, 2006Mount Sinai School of Medicine researchers publish first study showing link between diet and ALS
New York, New York --A recent study directed by the Mount Sinai School of Medicine suggests a ketogenic- high caloric diet may prevent the progression of Amyotrophic Lateral Sclerosis (ALS). This study, which appears in the April 3, 2006 issue of BMC Neuroscience, is the first to draw a correlation between diet and neuronal cell death, the cause of ALS.
ALS is an adult-onset neurodegenerative disorder in which spinal and cortical motor neurons die causing relentlessly progressive weakness and wasting of skeletal muscles through the body.
"ALS is such a devastating disease for those individuals diagnosed with the disorder," said Giulio Maria Pasinetti, M.D., Ph.D., Professor of Psychiatry and Neuroscience, Director of the Neuroinflammation Research Center at The Mount Sinai School of Medicine and lead author of this study. "The findings assert the significance of certain high caloric dietary intake in the prevention of ALS. In view of any available therapeutic application for the disease, this new evidence might bring hope to those affected."
The cause of neuronal death in ALS is uncertain but study researchers say mitochondrial dysfunction plays an important role. Ketones promote mitochondrial energy production and membrane stabilization. Mitochondiral membrane dysfunction, loss of oxidative stress control, generation of excessive free radicals, neurofilament accumulation, and excitotoxicity are all implicated in the onset of ALS.
About the Study
Mount Sinai School of Medicine investigators used a mouse model to examine the affects of a ketogenic diet (KD) on the progression of ALS. ALS mice were fed a high caloric - ketogenic diet (KD) and motor performance, longevity, and motor neuron counts were measured in treated and diseased mice. Because mitochondrial dysfunction plays a central role in neuronal cell death in ALS, the effect that the principal ketone body, D-รข-3 hydroxybutyrate (DBH), has on mitochondrial ATP generation and neuroprotection were studied.
Blood ketones were > 3.5 times higher in KD fed animals compared to controls. KD fed mice lost 50% of baseline motor performance 25 days later than the disease controls. The interaction between diet and change in weight was significant; KD mice weighed 4.6g more than the disease control group at study endpoint. In spinal cord sections obtained at the study endpoint, there were more motor neurons in KD fed animals. DBH prevented rotenone mediated inhibition of mitochondrial complex I but not malonate inhibition of complex II. Rotenone neurotoxicity in spinal cord motorneuron was also inhibited by DBH.
The Conclusions
This is the first study showing that diet, specifically a high caloric-KD, may slow the progression of the clinical and biological manifestations of ALS in a mouse model. This may be due to the ability of ketone bodies to promote ATP synthesis and bypass inhibition of complex I in the mitochondrial respiratory chain.
The Mount Sinai Hospital / Mount Sinai School of Medicine
"ALS is such a devastating disease for those individuals diagnosed with the disorder," said Giulio Maria Pasinetti, M.D., Ph.D., Professor of Psychiatry and Neuroscience, Director of the Neuroinflammation Research Center at The Mount Sinai School of Medicine and lead author of this study. "The findings assert the significance of certain high caloric dietary intake in the prevention of ALS. In view of any available therapeutic application for the disease, this new evidence might bring hope to those affected."
The cause of neuronal death in ALS is uncertain but study researchers say mitochondrial dysfunction plays an important role. Ketones promote mitochondrial energy production and membrane stabilization. Mitochondiral membrane dysfunction, loss of oxidative stress control, generation of excessive free radicals, neurofilament accumulation, and excitotoxicity are all implicated in the onset of ALS.
About the Study
Mount Sinai School of Medicine investigators used a mouse model to examine the affects of a ketogenic diet (KD) on the progression of ALS. ALS mice were fed a high caloric - ketogenic diet (KD) and motor performance, longevity, and motor neuron counts were measured in treated and diseased mice. Because mitochondrial dysfunction plays a central role in neuronal cell death in ALS, the effect that the principal ketone body, D-รข-3 hydroxybutyrate (DBH), has on mitochondrial ATP generation and neuroprotection were studied.
Blood ketones were > 3.5 times higher in KD fed animals compared to controls. KD fed mice lost 50% of baseline motor performance 25 days later than the disease controls. The interaction between diet and change in weight was significant; KD mice weighed 4.6g more than the disease control group at study endpoint. In spinal cord sections obtained at the study endpoint, there were more motor neurons in KD fed animals. DBH prevented rotenone mediated inhibition of mitochondrial complex I but not malonate inhibition of complex II. Rotenone neurotoxicity in spinal cord motorneuron was also inhibited by DBH.
The Conclusions
This is the first study showing that diet, specifically a high caloric-KD, may slow the progression of the clinical and biological manifestations of ALS in a mouse model. This may be due to the ability of ketone bodies to promote ATP synthesis and bypass inhibition of complex I in the mitochondrial respiratory chain.
The Mount Sinai Hospital / Mount Sinai School of Medicine
Amyotrophic Lateral Sclerosis News and Current Amyotrophic Lateral Sclerosis Events RSSData mining detects signs of Lou Gehrig's disease in gene carriers long before symptoms appear
Inspired by the use of microarray chips that look for gene combinations, psychologists are using "pattern array" software to spot movements in rats that might help them predict diseases such as Lou Gehrig's syndrome.
Protein plays Jekyll and Hyde role in Lou Gehrig's disease
Amyotrophic lateral sclerosis (ALS), more commonly known as Lou Gehrig's disease, is a fatal neurodegenerative disease caused by the death of motor neurons in the brain and spinal cord that control muscle movements from walking and swallowing to breathing. In a groundbreaking study this week in PLoS Biology, Brandeis and Harvard Medical School scientists report key findings about the cause and occurrence of the familial form of ALS.
New study of gene evolution could lead to better understanding of neurodegenerative disease
Genetic evolution is strongly shaped by genes' efforts to prevent or tolerate errors in the production of proteins, scientists at The University of Texas at Austin and Harvard University have found.
Researchers probe geographical ties to ALS cases among 1991 Gulf War veterans
Researchers from Duke University, the University of Cincinnati (UC) and the Durham Veterans Administration Medical Center are hoping to find a geographical pattern to help explain why 1991 Gulf War veterans contracted the fatal neurological disease amyotrophic lateral sclerosis (ALS) at twice the normal rate during the decade after the conflict.
Umbilical cord blood cell transplants may help ALS patients
A study at the University of South Florida has shown that transplants of mononuclear human umbilical cord blood (MNChUCB) cells may help patients suffering from Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease.
Genetics of ALS progression
An upcoming paper from Drs. Hidenori Ichijo and Hideki Nishitoh (The University of Tokyo) and colleagues lends new and valuable insight into the genetics of ALS.
Researchers uncover mechanism of action of antibiotic able to reduce neuronal cell death in brain
Virginia Commonwealth University researchers have discovered how an antibiotic works to modulate the activity of a neurotransmitter that regulates brain functions, which eventually could lead to therapies to treat Alzheimer's disease, Huntington's disease, epilepsy, stroke, dementia and malignant gliomas.
Penn researchers find potential in yeast for selecting Lou Gehrig's disease drugs
Researchers from the University of Pennsylvania School of Medicine are developing a novel approach to screen for drugs to combat neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, using yeast cells.
Leaky blood vessels open up nerve cells to toxic assault in Lou Gehrig's disease
Leaky blood vessels that lose their ability to protect the spinal cord from toxins may play a role in the development of amyotrophic lateral sclerosis, better known as ALS or Lou Gehrig's disease, according to research published in the April issue of Nature Neuroscience.
More genes for Lou Gehrig's disease identified, according to Penn researchers
In recent months a spate of mutations have been found in a disease protein called TDP-43 that is implicated in two neurodegenerative disorders: amyotrophic lateral sclerosis (ALS), also called Lou Gehrig's disease, and certain types of frontotemporal dementia (FTD). These mutations could potentially become candidates for drug targets.
More Amyotrophic Lateral Sclerosis News Articles
 | Tuesdays with Morrie: An Old Man, a Young Man, and Life's Greatest Lesson by Mitch Albom This true story about the love between a spiritual mentor and his pupil has soared to the bestseller list for many reasons. For starters: it reminds us of the affection and gratitude that many of us still feel for the significant mentors of our past. It also plays out a fantasy many of us have entertained: what would it be like to look those people up again, tell them how much they meant to us,... |
 | I Remember Running: The Year I Got Everything I Ever Wanted - and ALS by Darcy Wakefield A little over a year ago, Darcy Wakefield was a single, 33-year-old, athletic, workaholic English professor, a vegetarian who had never had a serious health problem or injury. Then she was diagnosed with ALS, and her world turned upside down. I Remember Running is Darcy's story of change and loss and challenges during her first year with ALS, as she struggles to make sense of her diagnosis and... |
 | Luckiest Man: The Life and Death of Lou Gehrig by Jonathan Eig Lou Gehrig started his professional baseball career at a time when players began to be seen as national celebrities. Though this suited charismatic men such as Babe Ruth and Joe DiMaggio, Gehrig avoided the spotlight and preferred to speak with his bat. Best known for playing in 2,130 consecutive games as well as his courage in battling amyotrophic lateral sclerosis (a disease that now bears his... |
 | Amyotrophic Lateral Sclerosis: A Guide for Patients and Families by Hiroshi Mitsumoto, Theodore L. Munsat This comprehensive guide covers every aspect of the management of ALS, beginning with discussions of clinical features of the disease, diagnosis, and an overview of symptom management. Major sections deal with medical and rehabilitative management, living with ALS, managing advanced disease, end-of-life issues, and resources that can provide support and... |
 | Tales from the Bed: A Memoir by Jenifer Estess, Valerie Estess Jenifer Estess is a beautiful, successful, thirtysomething New Yorker with dreams of starting her own family when she is diagnosed with ALS, a fatal disease. Doctors tell her to max out her credit cards and prepare to die. That is precisely when Jenifer starts to live -- dreaming deeper, working harder, and loving endlessly. A girlhood pact with her sisters Valerie and Meredith -- nothing will... |
 | Augie's Quest: One Man's Journey from Success to Significance by Augie Nieto, T.R. Pearson The inspiring story of a fitness pioneer whose ALS diagnosis leads him to create a new and revolutionary model for private medical research and development. What happens to “orphan” diseases that aren’t big enough profit centers for the pharmaceutical industry or get caught in the web of government funding and academic research? Augie Nieto found out in the spring of 2005: At... |
 | Learning to Fall: The Blessings of an Imperfect Life by Philip Simmons Now I find myself in late August, with the nights cool and the crickets thick in the fields. Already the first blighted leaves glow scarlet on the red maples. It’s a season of fullness and sweet longings made sweeter now by the fact that I can’t be sure I’ll see this time of the year again....— from Learning to FallPhilip Simmons was just thirty-five years old in 1993 when... |
 | Returning to Earth: A Novel by Jim Harrison Hailed by The New York Times Book Review as “a master … who makes the ordinary extraordinary, the unnamable unforgettable,” beloved author Jim Harrison returns with a masterpiece—a tender, profound, and magnificent novel about life, death, and finding redemption in unlikely places. Slowly dying of Lou Gehrig’s Disease, Donald, a middle-aged Chippewa-Finnish man,... |
 | Amyotrophic Lateral Sclerosis (American Academy of Neurology) by Robert G. Miller, Deborah Gelinas, Patricia O'Connor Amyotrophic Lateral Sclerosis is not a curable disease, but it is a treatable one. Treatments are now available that can make a major difference in prolonging life and enhancing the quality of life for people with the disease, and there are treatments for many of the symptoms of ALS that can help ease its burden. Multidisciplinary teams in specialized ALS centers are providing top quality care... |
 | Hope Springs Eternal: Surviving a Chronic Disease by David R. Atkinson The author a victim of a motor neuron disease, uses his own story to provide hope for those facing severe illness, for their caregivers and physicians, and for anyone who wants a preventative approach. Atkinson investigated alternative treatments and found ways to slow or reverse his... |
| © 2008 BrightSurf.com |